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A B S T R A C T
Urinary bladder cancers can be grouped into three general categories: superficial, in-
vasive and metastatic. Approximately 90% of malignant tumors of the urinary bladder
are of epithelial origin and the majority of them are transitional cell carcinomas (TCC).
Metastatic spread of urinary bladder cancers usually includes regional lymph nodes,
the lung, the liver and the bones. The presence of metastasis tends to correlate with mus-
cular wall invasion as often demonstrated at the initial diagnosis; consequently clinical
bladder cancer represents a late phase of the disease. Although skeletal metastases of
bladder cancers are rather common, they have been rarely described to occur in distal
bones. For that reason, we report metatarsal metastasis from transitional cell cancer of
the urinary bladder in a 59-year-old woman.
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Introduction
In a study of 107 patients who died of
metastatic transitional cell carcinoma
(TCC), the most common sites of meta-
stases at necropsy were the lymph nodes,
liver, lung, bone and adrenal gland1 but
other much more infrequent metastatic
sites such as orbit have also been descri-
bed2. Metastases were documented clini-
cally in multiple-organ sites in one third
of patients while solitary metastases
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were present in only 9 patients at necrop-
sy1. The mean duration of survival for pa-
tients was thirteen months from the diag-
nosis of the primary tumor1. The meta-
static lesions were generally evident clin-
ically within eleven months of the pri-
mary diagnosis; death ensued usually
within three months1.
Bone metastases in bladder cancer oc-
cur rather often. Generally, they indicate
a poor prognosis for the patient. Meta-
stases may reach the skeleton by direct
invasion from the primary tumor or by
extension from the secondary site, such
as a lymph node. Direct invasion is usu-
ally accompanied by a detectable soft tis-
sue mass, an unusual feature of metasta-
ses that occur by haematogenous spread3
an event far more frequent than lym-
phatic spread or direct invasion. Here we
report a case of TCC of the urinary blad-
der with isolated primary bone metasta-
sis to the metatarsus.
Case report
A 59-year-old woman was hospitalized
at the Department of Urology due to se-
vere haematuria caused by a tumor mass
of the urinary bladder. Transurethral re-
section of the tumor mass was performed
immediately after the admittance to the
hospital to stop the bleeding. The diagno-
sis of undifferentiated transitional cell
carcinoma was established. Radical cys-
tectomy, adnexectomy and appendectomy
were performed followed by uretheroileo-
cutaneostomy after Bricker. The tumor
was staged as T4 N0 M0. The patho-
histological finding confirmed the diagno-
sis of undifferentiated transitional cell
carcinoma with lymphangiosis carcino-
matosa. All the analyzed regional lymph
nodes were negative.
After resection, the patient was ad-
mitted to the Department of Oncology
and Radiotherapy. According to the stage
of the tumor our patient underwent che-
motherapy in which the regimen with
CMV (Cisplatin, Methotrexate and Vin-
blastine) was used. She sustained the
treatment very well with abundant hy-
dration and antiemetics. At that point of
time all other examinations (bone scin-
tigraphy, X-rays of lungs, ultrasound of
the abdomen and internistic findings)
were normal.
One month later, at the beginning of
the second cycle of chemotherapy the pa-
tient complained of severe pain in the
metatarsal part of her left foot. This was
edematous, red and livid. X-rays indi-
cated severe, intensive demineralization
and bone atrophy with destruction of the
majority of the second metatarsal bone
probably of secondary nature (Figure 1).
A fine needle aspiration cytology of bone
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Fig. 1. X-ray of the left foot indicating complete
destruction of the majority of the second meta-
tarsal bone.
was performed. Cytology revealed differ-
entiated epithelial cells consisting meta-
stases. Within a month the progression of
metastatic disease was evident. X-rays
demonstrated the destruction of the sec-
ond metatarsal bone with a novel de-
struction of the nearby bone of the tarsus.
In the middle part of the left tibial dia-
physis osteolitic focuses were also seen at
that time. Bone scintigraphy performed
15 days later showed multiple zones of
pathological activity in bones of both lower
extremities. To relieve the pain the pa-
tient was administered palliative radio-
therapy of osteolitic regions with mega-
voltage photons.
In spite of cytostatic therapy and pal-
liative irradiation the disease progressed
quickly. Since the patient had complained
of severe pains she was treated by strong
analgetics, sometimes even narcoanalge-
tics, antirheumatics and sedatives. Our
patient was again hospitalized for symp-
tomatic therapy and one month later, she
died due to advanced metastasis.
Discussion
Approximately 90% of malignant tu-
mors of the urinary bladder are of epithe-
lial origin, the vast majority being transi-
tional cell carcinomas (TCC)4. The presen-
ce of TCC metastases tends to correlate
with muscular wall invasion and both are
often present at the initial diagnosis5.
Some other types of urinary bladder car-
cinomas, which occur more rarely, like su-
perficial papillary tumors, can be present
with no evidence of muscle invasion in de-
veloped distant metastases6. The frequen-
cy of metastatic sites is the highest in the
lymph nodes, liver, lung, bone and adre-
nal gland1,7, while metastases to some
others locations like pleura, kidney, peri-
toneum and intestine occur with a lower
incidence8. Although skeletal metastases
of the bladder cancer are rather common
their frequency varies considerably with
the type of the primary tumor9,10. A re-
cent study has confirmed that bone is the
preferred site of metastasis (35%) of TCC
outside the pelvis, with the spine being
the most common site (40% of metasta-
ses)11. The multiple metastases of TCC
are more frequent than a solitary meta-
stases1and can be found in multiple-or-
gan locations affecting the humerus, fe-
mur, spine, iliac wing and ribs11.
Metastases may reach the skeleton by
direct invasion from the primary tumor
or by extension from the secondary site.
True lymphatic spread to the skeleton is
rare. Direct invasion is usually accompa-
nied by a detectable soft tissue mass, un
unusual feature of metastases that occur
by hematogenous spread. The left sides of
the vertebral bodies are more frequently
affected by direct invasion from the local
lymph nodes because the left sided lymph
nodes are closer to bone than the right-
sided ones3. Haematogenous spread is far
more frequent than lymphatic spread or
direct invasion3,6. The venous route, espe-
cially Batson’s paravertebral plexus, ap-
pears to be more important than the arte-
rial route. The distribution of Batson’s
venous plexus, as well as the overall skel-
etal vascularity, results in a predilection
for haematogenous spread to the axial
skeleton12 and the proximal long bones3.
But sometimes distal bone metastases of
TCC of the bladder are found in knee12,
tarsus13 and metatarsus as described in
our case. Bone metastases demonstrated
either an osteoblastic or a mixed osteo-
lytic-osteoblastic pattern in 47% of the
instances14.
Bone pain in skeletal metastases is
frequently the presenting symptom. It
may be due to various mechanisms, in-
cluding the release of chemical media-
tors, elevated intraosseous pressure and
periostal elevation15. Pain may also re-
sult from pathologic or impeding frac-
ture, particulary in weight-bearing bo-
nes9.
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The frequency of skeletal metastases
also varies with the methodology used for
their detection9. It is interesting that his-
tologic type of tumor has no effect on the
frequency and location of metastases8.
Generally, these patients have a poor
prognosis and different survival period.
In one series, only 4 of 578 patients were
free of disease 10 years after the diagno-
sis of bone disease. Mean survival for pa-
tients with all primaries was five months
after diagnosis16 while in the previously
mentioned study of 107 patients the
mean duration of survival for patients
was thirteen months from the diagnosis
of the primary tumor1. It is interesting
that the pathological stage, lymph node
metastasis and vascular involvement, but
not tumor grade, were significantly use-
ful prognostic factor in patients who un-
derwent radical cystectomy for TCC. In
addition, among them only the pathological
stage and lymph node metastasis could
be used as independent predictors for poor
prognosis17.
Clinicians should be aware of the fact
that bone metastasis from transitional
cell carcinoma of the urinary bladder is
relatively frequent. However, distal osse-
ous lesions are a rare condition usually
appearing in the advanced disease as ob-
served in our patient.
R E F E R E N C E S
1. BABAIAN, R. J., D. E. JOHNSON, L. LIA-
MAS, A. G. AYALA, Urology, 16 (1980) 142. — 2. FE-
LIP, E., M. A. ROVIROSA, A. SALUD, F. CAPDEVI-
LA, J. BELLMUNT, J. GIRALT, Urol. Int., 46 (1991)
82. — 3. FISHER, M. S., Radiology, 134 (1980) 631. —
4. MOSTOFI, F. K., L. H. SOBIN, H. TORLONI, His-
tologic typing of urinary bladder tumors. In: Interna-
tional histological classification of tumors. (World
Health Organization, Geneva, 1973). — 5. PROUT, G.
R. JR., P. P. GRIFFIN, W. U. SHIPLEY, Cancer, 43
(1979) 2532. — 6. MATTHEWS, P. N., M. MADDEN,
K. A. BIDGOOD, C. FISHER, J. Urol., 132 (1984)
904. — 7. FRIEDELL, G. H., R. L. MCCAULEY, J.
Urol., 100 (1968) 293. — 8. WALLMEROTH, A., U.
WAGNER, H. MOCH, T. C. GASSER, G. SAUTER,
M. J. MIHATSCH, Urol. Int., 62 (1999) 69. — 9. RO-
SENTHAL, D. I., Radiologic diagnosis of bone meta-
stases cancer. In: Proceedings. (Skeletal Complica-
tions of Malignancy, Bethesda, 1997). — 10. TABBA-
RA, W. S., A. R. MEHIO, Prog. Clin. Biol. Res., 162A
(1984) 145. — 11. PUNYAVORAVUT, V., S. D. NEL-
SON, J. Med. Assoc. Thai, 82 (1999) 839. — 12.
ADRIAZOLA SEMINO, M., R. ORTIZ CABRIA, E.
GARCIA COBO, E. TEJEDA BANEZ, A. ALONSO
VILLALBA, F. ROMERO RODRIGUEZ, Arch. Esp.
Urol., 55 (2002) 69. — 13. DUMONTET, C., J. TEBIB,
E. NOEL, M. BOUYSSET, F. COLSON, M. BOU-
VIER, Ann. Radiol. (Paris), 30 (1987) 65. — 14. GOL-
DMAN, S. M., A. A. FAJARDO, R. C. NARAVAL, J. E.
MADEWELL, AJR Am. J. Roentgenol., 132 (1979)
419. — 15. RESNICK, D., G. NIWAYAMA, Skeletal
metastases. In: RESNICK, D., G. NIWAYAMA (Eds.):
Diagnosis of bone and joint disorders. (Philadelphia,
1988). — 16. ALCALA, Y., I. AZAIS, B. BRIDEON, P.
BABIN, P. VANDERMARCO, F. DEBIAS, D. BON-
TOUX, Revue du Rhumatisme, 62 (1995) 632. — 17.
HARA, S., H. MIYAKE, M. FUJISAWA, H. OKADA,
S. ARAKAWA, S. KAMIDONO, I. HARA, Jpn. J. Clin.
Oncol., 31 (2001) 399.
D. Muhvi}
Department of Physiology and Immunology, School of Medicine, University of Rijeka,
B. Branchetta 20/1, 51000 Rijeka, Croatia
340
M. Petkovi} et al.: Metatarsal Metastasis, Coll. Antropol. 28 (2004) 1: 337–341
METATARZALNA METASTAZA KARCINOMA PRIJELAZNIH STANICA
MOKRA]NOG MJEHURA
S A @ E T A K
Karcinomi mokra}nog mogu biti grupirani u tri op}e kategorije: povr{ni, invazivni i
metastatski. Pribli`no 90% malignih tumora mokra}nog mjehura je epitelnog porijekla
a ve}ina su karcinomi prijelaznih stanica (KPS). Metastatsko {irenje karcinoma mo-
kra}nog mjehura obi~no uklju~uje regionalne limfne ~vorove, plu}a, jetru i kosti. Pri-
sutnost metastaza ima tendenciju korelacije sa invazijom mi{i}ne stjenke {to je ~esto
pokazano pri po~etnoj dijagnozi; posljedi~no tome klini~ki karcinomi mokra}nog mje-
hura predstavljaju kasni stadij bolesti. Iako su skeletne metastaze karcinoma mokra-
}nog mjehura prili~no ~este, rijetko je opisano da se javljaju u distalnim kostima. Stoga
mi opisujemo rijetku metatarzalnu metastazu karcinoma prijelaznih stanica mokra-
}nog mjehura u 59-godi{nje `ene.
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